Single Nucleus Transcriptomics Reveals Pervasive Glial Activation in Opioid Overdose Cases
Wei, J.; Lambert, T. Y.; Valada, A.; Patel, N.; Walker, K.; Lenders, J.; Schmidt, C. J.; Iskhakova, M.; Alazizi, A.; Mair-Meijers, H.; Mash, D. C.; Luca, F.; Pique-Regi, R.; Bannon, M. J.; Akbarian, S.
Show abstract
Dynamic interactions of neurons and glia in the ventral midbrain (VM) mediate reward and addiction behavior. We studied gene expression in 212,713 VM single nuclei from 95 human opioid overdose cases and drug-free controls. Chronic exposure to opioids left numerical proportions of VM glial and neuronal subtypes unaltered, while broadly affecting glial transcriptomes, involving 9.5 - 6.2% of expressed genes within microglia, oligodendrocytes, and astrocytes, with prominent activation of the immune response including interferon, NFkB signaling, and cell motility pathways, sharply contrasting with down-regulated expression of synaptic signaling and plasticity genes in VM non-dopaminergic neurons. VM transcriptomic reprogramming in the context of opioid exposure and overdose included 325 genes with genetic variation linked to substance use traits in the broader population, thereby pointing to heritable risk architectures in the genomic organization of the brains reward circuitry.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.